Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Telo Genomics Corp (TELO.VN)

Telo Genomics Corp (TELO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 12,123
  • Shares Outstanding, K 71,310
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,821 K
  • 60-Month Beta 0.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.06
Trade TELO.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Diagnostics & Research

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.105 +61.90%
on 04/02/24
0.225 -24.44%
on 04/18/24
+0.045 (+36.00%)
since 03/26/24
3-Month
0.105 +61.90%
on 04/02/24
0.225 -24.44%
on 04/18/24
+0.010 (+6.25%)
since 01/26/24
52-Week
0.105 +61.90%
on 04/02/24
0.335 -49.25%
on 06/13/23
-0.105 (-38.18%)
since 04/26/23

Most Recent Stories

More News
Telo Genomics Receives Accreditation from College of American Pathologists

Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial

Toronto, Ontario--(Newsfile Corp. - April 2, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients

Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has received the first patient sample for...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
BMY : 44.85 (+0.34%)
TMO : 573.60 (+0.33%)
NTRA : 91.66 (+0.42%)
NEO : 14.14 (+2.09%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
BMY : 44.85 (+0.34%)
TMO : 573.60 (+0.33%)
NTRA : 91.66 (+0.42%)
NEO : 14.14 (+2.09%)
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US

Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has engaged Trusted Health Advisors (THA),...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Gears up for American Society of Hematology Conference

Toronto, Ontario--(Newsfile Corp. - December 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), an emerging molecular testing platform provider leveraging...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Launches Physician Experience Program in the United States

SMART Observational Study a Critical Step Toward Full Platform AvailabilityToronto, Ontario--(Newsfile Corp. - November 16, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company"...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists

An Important Accreditation Milestone Achieved Towards Full Commercial AvailabilityToronto, Ontario--(Newsfile Corp. - November 7, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A), (the...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting

ASH is the world leader in supporting clinical and scientific hematology researchToronto, Ontario--(Newsfile Corp. - November 1, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

See More

Key Turning Points

3rd Resistance Point 0.178
2nd Resistance Point 0.177
1st Resistance Point 0.173
Last Price 0.170
1st Support Level 0.168
2nd Support Level 0.167
3rd Support Level 0.163

See More

52-Week High 0.335
Fibonacci 61.8% 0.247
Fibonacci 50% 0.220
Fibonacci 38.2% 0.193
Last Price 0.170
52-Week Low 0.105

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar